Similar Stories to Bristol Will Buy Diabetes Drug Maker on Bing News

Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.

BING NEWS:
  • Is Bristol Myers Squibb A Buy At These Bottom Levels?
    For context, BMY has previously offered a relatively promising FY2024 guidance, with revenue growth of low single digits and adj EPS of $7.25 at the midpoint (-3.4% YoY excluding impact of ...
    04/22/2024 - 2:30 am | View Link
  • Newer diabetes drugs considered low-value options, updated guideline finds
    The quest for effective treatments to treat type 2 diabetes has taken a turn with new drugs in the spotlight. In response, the American College of Physicians (ACP) recently released an updated ...
    04/20/2024 - 6:13 am | View Link
  • Got $500? 3 Healthcare Stocks to Buy and Hold Forever
    Make the most of a modest investment by putting it into Intuitive Surgical, Bristol Myers Squibb, and Novo Nordisk.
    04/19/2024 - 1:15 am | View Link
  • Oswego alumnus discussesscientific career paths
    SUNY Oswego welcomed Bruce Ellsworth, a 1987 alumni of the university to present the Augustine Silveria Jr. Distinguished Lecture Series, “Becoming a Scientist: The Path from ...
    04/18/2024 - 10:25 am | View Link
  • Tampa native helping children with Type 1 diabetes through scholarships and mentorship
    A Tampa woman living with Type 1 diabetes used her life experience to launch an organization that uplifts and helps minority youth dealing with the disease as well.
    04/17/2024 - 3:11 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News